IL6 and metabolic dysfunction-associated steatotic liver disease: The flavonoid hesperidin significantly enhances GLP-1 secretion and reduces pro-inflammatory biomarkers such as IL-6, TNF-α, and hsCRP in both clinical and preclinical models of non-alcoholic fatty liver disease (27).